Abstract:Background Subtle cognitive decline (SCD) may represent a very early stage of objective cognitive impairment before mild cognitive impairment (MCI), with less neuronal damage and more functional reservation. Detecting individuals with SCD is imperative for dementia prevention and treatment. In this study, we aimed to compare the validations of three cognitive screening tests, Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment-Chinese Version (MoCA-CV), and Memory and Executive Screening (MES), in identifying subtle cognitive decline. Methods A total of 407 individuals were recruited, including 147 cognitively normal controls (NC), 102 individuals with subtle cognitive decline (SCD) and 158 individuals with mild cognitive impairment (MCI) according to the operational neuropsychological criteria proposed by Jak and Bondi’s. All participants underwent standardized comprehensive neuropsychological tests and the three cognitive screening tests. Chi-square analysis was used to compare the cognitive performance among the groups of NC, SCD and MCI. Receiver operating characteristic (ROC) curves were used to evaluate the abilities of MMSE, MoCA-CV and MES in discriminating NC, SCD and MCI. Results Compared with NC, SCD showed a significant decline only in the tests of memory, such as Auditory Verbal Learning Test (AVLT), Rey-Osterrieth Complex Figure Test (CFT) and Prospective Memory Test (PrM) ( P < 0.01). However, MCI showed significant decline in all cognitive performances ( P < 0.01). The scores of MMSE, MoCA-CV and MES all showed a progressive downward trend within the groups of NC, SCD and MCI ( P < 0.001). In ROC Analyses for discriminating individuals with SCD from NC, the most appropriate MES cutoff was 84, with a sensitivity of 74.3%, a specificity of 60.8% and 0.738 for AUC (95%CI, 0.675–0.801). By contrast, MMSE and MOCA-CV had poor sensitivity (67.4 and 70.8%, respectively) and specificity (51.0 and 52.9%, respectively), and smaller AUCs (0.643 and 0.644, respectively) than the MES. Conclusion As a screening test, MES is more efficacious in identifying SCD from normal controls than MMSE and MoCA-CV.

Correlation between ankle‐brachial index and subtle cognitive decline

A Risk Factor Analysis of Cognitive Impairment in Elderly Patients with Chronic Diseases in a Chinese Population

Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults

Altered Functional Connectivity Pattern of Hippocampal Subfields in Individuals with Objectively-Defined Subtle Cognitive Decline and Its Association with Cognition and Cerebrospinal Fluid Biomarkers

Validity of Cognitive Function Assessed by a Subjective Cognitive Decline Questionnaire As Compared with Objective Cognitive Tests in Community‐dwelling Older Adults in China

Subtle Cognitive Impairment As a Marker of Alzheimer's Pathologies and Clinical Progression in Cognitively Normal Individuals

Analysis of the Relationship Between Blood Pressure Variability and Subtle Cognitive Decline in Older Adults

Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study

Relationship Between Ankle-Brachial Index and Ischemic Stroke in Chinese Patients

The characteristics of arterial spin labeling cerebral blood flow in patients with subjective cognitive decline: The Chinese imaging, biomarkers, and lifestyle study

Correlation of Ankle-Arm Blood Pressure and Coronary Artery Disease in Older Patients with Coronary Heart Disease

A Comparative Study on the Validations of Three Cognitive Screening Tests in Identifying Subtle Cognitive Decline

Subjective Cognitive Decline is Associated with a Higher Risk of Objective Cognitive Decline: A Cross-Sectional and Longitudinal Study

[P1–374]: ALTERATION OF HIPPOCAMPUS AND AMYGDALA IN SUBJECTIVE COGNITIVE DECLINE AND MILD COGNITIVE IMPAIRMENT IN COMMUNITY‐DWELLING CHINESE

Clinical Study on Correlations of Abnormal Ankle-Brachial Index with the Extent of Coronary Atherosclerosis Lesions

Impaired glymphatic function as a biomarker for subjective cognitive decline: An exploratory dual cohort study

Relationship of Ankle–brachial Index with All-Cause Mortality and Cardiovascular Mortality after a 3-Year Follow-Up: the China Ankle–brachial Index Cohort Study

Changes in Multiparametric Magnetic Resonance Imaging and Plasma Amyloid-Beta Protein in Subjective Cognitive Decline

Usefulness of ankle-Bravhial Index to Predict the Extent of Coronary Atnerosclerosis and Cardiovascular Events in Patiens With Coronary Artery Disease

Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.

The Association between Ankle-Brachial Index and Cardiovascular or All-Cause Mortality in Metabolic Syndrome of Elderly Chinese